Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Eli Lilly $500 million South Korea biopharma pledge

Lucid Diligence Brief: Eli Lilly $500 million South Korea biopharma pledge…


Endocrinology

Endocrinology Today—March 10, 2026

This week’s Endocrinology update highlights regulatory progress in osteoporosis…


Obesity Weekly News

Obesity Today—March 10, 2026

This week’s Obesity update highlights regulatory approvals, emerging generic…


Endocrinology

Endocrinology Today—March 3, 2026

This week’s Endocrinology update highlights regulatory approvals, Phase 3…


Immunology

Immunology Video Recap—February 25, 2026

This biweekly Immunology video recap highlights key developments across…


Immunology

Immunology Today—February 25, 2026

This week's Immunology update summarizes covering clinical-trial readouts and…


Obesity Weekly News

Obesity Today—February 24, 2026

This week's Obesity update highlights regulatory decisions, late-stage clinical…


Onco_background

Oncology Today—February 23, 2026

This week's Oncology update covers  a mix of regulatory actions, filing…


Cell_Gene_Therapy

Cell and Gene Therapy Video Recap—February 19, 2026

This biweekly Cell and Gene Therapy video recap covers the latest regulatory…


Cell and Gene Therapy News

Cell and Gene Therapy Video Recap—February 19, 2026

This biweekly Cell and Gene Therapy video recap covers the latest regulatory…


Immunology

Immunology Today—February 18, 2026

This week's Immunology update summarizes key developments in clinical trials,…


Cell_Gene_Therapy

Cell and Gene Therapy Today—February 12, 2026

This week's Cell and Gene Therapy update highlights key regulatory actions,…


Privacy Preference Center